DA-2803
/ Dong-A
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 23, 2024
Clinical Study to Evaluate the Efficacy and Safety of DA-2803 in Chronic Hepatitis B Patients
(clinicaltrials.gov)
- P4 | N=120 | Completed | Sponsor: Dong-A ST Co., Ltd. | Recruiting ➔ Completed | Trial primary completion date: Feb 2024 ➔ Sep 2024
Trial completion • Trial primary completion date • Hepatitis B • Hepatology • Infectious Disease • Inflammation
1 to 1
Of
1
Go to page
1